These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6213588

  • 21. Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses.
    Shibata T, Shibamoto Y, Oya N, Sasai K, Murata R, Ishigaki T, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):587-90. PubMed ID: 8005820
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer.
    Sasai K, Nishimoto S, Shimokawa K, Hisanaga Y, Kitakabu Y, Shibamoto Y, Zhou L, Wang J, Takahashi M, Kagiya T.
    Int J Radiat Oncol Biol Phys; 1991 Jun 15; 20(6):1249-54. PubMed ID: 1828462
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM, Yu NY, Brown JM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1982 Jun 15; 8(3-4):435-8. PubMed ID: 7107364
    [Abstract] [Full Text] [Related]

  • 26. Experimental intra-arterial administration of SR-2508 in the rabbit V2 carcinoma model.
    Coldwell DM, Huff J, Marcellus H, Coldwell SG.
    Br J Radiol; 1989 Mar 15; 62(735):234-6. PubMed ID: 2522804
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM, Dionet C, Brown JM.
    Radiat Res; 1984 Jan 15; 97(1):162-70. PubMed ID: 6229806
    [Abstract] [Full Text] [Related]

  • 28. Radiosensitization of the RIF-1 murine flank tumor by desmethylmisonidazole (Ro 05 9963) during interstitial brachytherapy.
    Bernstein M, Gutin PH, Deen DF, Weaver KA, Levin VA, Barcellos MH.
    Int J Radiat Oncol Biol Phys; 1982 Jan 15; 8(3-4):487-90. PubMed ID: 7107372
    [Abstract] [Full Text] [Related]

  • 29. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K, Takahashi M, Nishidai T, Dodo Y, Shibamoto Y, Hiraoka M, Yukawa Y, Abe M.
    Radiat Med; 1984 Jan 15; 2(1):71-5. PubMed ID: 6242712
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile.
    Coleman CN, Halsey J, Cox RS, Hirst VK, Blaschke T, Howes AE, Wasserman TH, Urtasun RC, Pajak T, Hancock S.
    Cancer Res; 1987 Jan 01; 47(1):319-22. PubMed ID: 3024818
    [Abstract] [Full Text] [Related]

  • 32. Clinical trials of radiosensitizers: what should we expect?
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Mar 01; 10(3):425-9. PubMed ID: 6231272
    [Abstract] [Full Text] [Related]

  • 33. [Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
    Ono K, Takahashi M, Hamanaka D, Hiraoka M, Nishidai T, Abe M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb 25; 43(2):370-6. PubMed ID: 6223274
    [No Abstract] [Full Text] [Related]

  • 34. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF, Bleehen NM, Ward R, Workman P.
    Int J Radiat Oncol Biol Phys; 1988 Sep 25; 15(3):677-84. PubMed ID: 2843488
    [Abstract] [Full Text] [Related]

  • 35. Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): a radiation therapy oncology group study.
    Coleman CN, Noll L, Howes AE, Harris JR, Zakar J, Kramer RA.
    Int J Radiat Oncol Biol Phys; 1989 Apr 25; 16(4):1085-7. PubMed ID: 2522919
    [Abstract] [Full Text] [Related]

  • 36. Pharmacology and clinical investigation of SR-2508 (etanidazole).
    O'Dwyer PJ, LaCreta FP.
    Cancer Treat Res; 1991 Apr 25; 58():45-63. PubMed ID: 1683785
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and toxicology of continuously infused nitroimidazoles.
    Eifel PJ, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Aug 25; 10(8):1311-4. PubMed ID: 6236186
    [Abstract] [Full Text] [Related]

  • 38. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y, Sakano K, Kimura R, Nishidai T, Nishimoto S, Ono K, Kagiya T, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Jul 25; 12(7):1063-6. PubMed ID: 3744928
    [Abstract] [Full Text] [Related]

  • 39. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer.
    Hori H, Murayama C, Mori T, Shibamoto Y, Abe M, Onoyama Y, Inayama S.
    Int J Radiat Oncol Biol Phys; 1989 Apr 25; 16(4):1029-32. PubMed ID: 2703381
    [Abstract] [Full Text] [Related]

  • 40. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF, Ward R, Workman P, Bleehen NM.
    Int J Radiat Oncol Biol Phys; 1988 Nov 25; 15(5):1073-83. PubMed ID: 2972667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.